MPO and colitis: Previous studies have shown that TQ treatment mitigated colonic inflammation with a reduction in colonic myeloperoxidase activity, malondialdehyde, and increased glutathione levels in dextran sulfate sodium (DSS)-induced colitis in mice [20].